ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI picks who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingThis study tests whether a computer model can help decide which liver cancer patients should receive immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from coming back. About 300 adults who had their liver cancer completely removed will be enrolled. The goal is …
Matched conditions: ADJUVANT THERAPY
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
New drug cocktail aims to stop cervical cancer from coming back after surgery
Disease control Not yet recruitingThis study tests whether combining two drugs, camrelizumab and famitinib, can help prevent cervical cancer from returning after surgery. About 30 adults with a specific type of cervical cancer that tests positive for PD-L1 will receive the treatment. The main goal is to see how m…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: Jin LI • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
New drug aims to stop throat cancer from coming back
Disease control Not yet recruitingThis study tests a new drug, Becotatug vedotin, against a standard chemotherapy pill (capecitabine) to see which is better at preventing cancer from returning in people with advanced nasopharyngeal cancer. About 218 adults who have already completed standard chemoradiation will b…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 11, 2026 20:41 UTC